Advances in Dermatology and Allergology
facebook
eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Reviewers Instructions for authors Publication charge
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2026
vol. 43
 
Share:
Send email
Share:
Original paper

Psychological distress statistically mediates the association between vitiligo severity and health-related quality of life: a cross-sectional study from Kandahar, Afghanistan

Khushhal Farooqi
1, 2
,
Sandesh Kumar Sharma
3
,
Zarghoon Tareen
2, 4
,
Najibullah Rafiqi
5
,
Mohammad Hashim Wafa
6
,
Naqibullah Razi
7

  1. Department of Dermatology, Medical Faculty, Kandahar University, Kandahar, Afghanistan
  2. PhD Scholar, Department of Public Health, IIHMR University, Jaipur, India
  3. Department of Public Health, SD Gupta School of Public Health, IIHMR University, Jaipur, India
  4. Department of Paediatrics, Medical Faculty, Kandahar University, Kandahar, Afghanistan
  5. Department of Surgery, Medical Faculty, Kandahar University, Kandahar, Afghanistan
  6. Medical Faculty, Kandahar University, Kandahar, Afghanistan
  7. Mohmand Hospital, Kandahar, Afghanistan
Adv Dermatol Allergol 2026; XLIII (2): 179–184
DOI: https://doi.org/10.5114/ada.2026.161097
Online publish date: 2026/04/16
Article file
- Psychological distress.pdf  [0.16 MB]
Get citation
 
 
1. World Health Organization. Global Health Observatory: Afghanistan mental health. 2021.
2. Akl JA, Lee S, Ju HJ, et al. Estimating the burden of vitiligo: a systematic review and modelling study. Lancet Public Health 2024; 9: e386-96.
3. Bibeau K, Grimes P, Harris JE, van Geel N; VALIANT Study Group. Mental health and psychosocial quality-of-life burden among patients with vitiligo. JAMA Dermatol 2023; 159: 1167-75.
4. Ezzedine K, Eleftheriadou V, Jones H, et al. Psychosocial effects of vitiligo: systematic review. Am J Clin Dermatol 2021; 22: 757-74.
5. Rosmarin D, Soliman AM, Piercy J, et al. Health-related quality of life burden among adults with vitiligo: relationship to disease severity and disease location. Dermatol Ther (Heidelb) 2024; 14: 1633-47.
6. Bae JM, Lee SC, Kim TH, et al. Factors affecting quality of life in vitiligo. Br J Dermatol 2018; 178: 238-44.
7. AlGhamdi KM. Beliefs and perceptions of Arab vitiligo patients. Int J Dermatol 2010; 49: 1141-5.
8. Singla S, Malik YK, Dayal S, Gupta R. Psychological symptoms in vitiligo. J Neurosci Rural Pract 2025; 16: 174-8.
9. Hedayat K, Karbakhsh M, Ghiasi M, et al. Quality of life in vitiligo patients. Health Qual Life Outcomes 2016; 14: 86.
10. Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 2015; 135: 984-91.
11. Nasser MAEM, El Tahlawi SMR, Abdelfatah ZA, et al. Stress, anxiety, and depression in patients with vitiligo. Middle East Curr Psychiatry 2021; 28: 63.
12. Qin X. An introduction to causal mediation analysis. Asia Pac Educ Rev 2024; 25: 703-17.
13. Awal G, Kaur N, Singh G, et al. Impact of vitiligo on quality of life in patients of skin of color and its correlation with clinical severity assessment scores utilizing disease specific scores: a cross-sectional study. Dermatol Pract Concept 2024; 14: e2024075.
14. MacKinnon DP, Lockwood CM, Williams J. Confidence limits for the indirect effect. Multivariate Behav Res 2004; 39: 99-128.
15. Taieb A, Picardo M. Definition and assessment of vitiligo. Pigment Cell Res 2007; 20: 27-35.
16. Merhi R, Canu D, Barnetche T, et al. Assessment of Vitiligo Area Scoring Index (VASI), Facial-VASI and Vitiligo Extent Score using standardized photography of patients with vitiligo. Br J Dermatol 2022; 187: 422-24.
17. Goldberg DP, Hillier VF. General Health Questionnaire (GHQ). Psychol Med 1979; 9: 139-45.
18. Hamilton M. Hamilton Anxiety Rating Scale. Br J Med Psychol 1959; 32: 50-5.
19. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573-83.
20. Basra MKA, Fenech R, Gatt RM, et al. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
21. Vyas J, Johns JR, Ali FM, et al. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries. Br J Dermatol 2024; 190: 315-39.
22. Sousa VD, Rojjanasrirat W. Translation and cross-cultural validation. J Eval Clin Pract 2011; 17: 268-74.
23. World Health Organization. Translation methodology. 2021.
24. Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research. J Pers Soc Psychol 1986; 51: 1173-82.
25. Silpa-archa N, Pruksaeakanan C, Angkoolpakdeekul N, et al. Relationship between depression and quality of life among vitiligo patients: a self-assessment questionnaire-based study. Clin Cosmet Investig Dermatol 2020; 13: 511-20.
26. Rahimi BA, Farooqi K, Fazli N. Clinical patterns of vitiligo in Kandahar. Our Dermatol Online 2020; 11: 6-12.
27. van Geel N, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm. J Eur Acad Dermatol Venereol 2023; 37: 2173-84.
28. Ferreira BR, Vulink N, Mostaghimi L, et al. Classification of psychodermatological disorders: proposal of a new international classification. J Eur Acad Dermatol Venereol 2024; 38: 645-56.
29. Bassiouny D, Hegazy R, Esmat S, et al. Cosmetic camouflage as an adjuvant to vitiligo therapies: effect on quality of life. J Cosmet Dermatol 2021; 20: 159-65.
30. Maxwell SE, Cole DA. Bias in cross-sectional mediation. Psychol Methods 2007; 12: 23-44.
31. Kussainova A, Kassym L, Akhmetova A, et al. Vitiligo and anxiety: a systematic review and meta-analysis. PLoS One 2020; 15: e0241445.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.